| (V981) |
Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation |
|
L. Ueberham, A. Bollmann, A. Arya, V. Adams, G. Hindricks, D. Husser (Leipzig) |
| (V982) |
Failure of the Centri-petal Calcium Wave Propagation in Field-Stimulated Atrial Myocytes Isolated from Patients with Persistent Atrial Fibrillation. |
|
B.-G. Kerfant, M. Greiser, S. Verheule, J. Maessen, U. Schotten (Maastricht, NL; Baltimore, US) |
| (V983) |
Incidence of potentially proarrhythmic spontaneous Ca2+ release events is increased in patients with paroxysmal atrial fibrillation
|
|
N. Voigt, D. Dobrev (Essen) |
| (V984) |
The mineralocorticoid receptor promotes structural remodeling in atrial fibrillation |
|
D. Lavall, C. Selzer, P. Schuster, O. Adam, H.-J. Schäfers, M. Böhm, U. Laufs (Homburg/Saar) |
| (V985) |
Mutations of genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation for atrial fibrillation |
|
D. Husser, L. Ueberham, G. Hindricks, C. Ingram, D. Darbar, P. Weeke, V. Adams, D. Roden, A. Bollmann (Leipzig; Nashville, US) |
| (V986) |
MicroRNAs as potential biomarkers in atrial fibrillation therapy – first insights |
|
S. Clauß, V. Schmidt, I. Klier, F. V. Schüßler, J. Siebermair, H. L. Estner, S. Kääb, R. Wakili (München) |